Ultralife (NASDAQ:ULBI – Get Free Report) is projected to post its quarterly earnings results before the market opens on ...

ARM (NASDAQ:ARM – Free Report) had its price target lowered by Morgan Stanley from $175.00 to $150.00 in a research note ...

Acumen Pharmaceuticals (NASDAQ:ABOS – Free Report) had its price target trimmed by HC Wainwright from $15.00 to $11.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage ...

FBN Securities began coverage on shares of AppLovin (NASDAQ:APP – Free Report) in a research report sent to investors on Friday, MarketBeat.com reports. The firm issued an outperform rating and a $385 ...

BMO Capital Markets upgraded shares of Check Point Software Technologies (NASDAQ:CHKP – Free Report) from a market perform rating to an outperform rating in a research report released on Friday ...

Equities researchers at Zacks Research reduced their Q3 2025 earnings per share (EPS) estimates for shares of Zscaler in a ...

Equities research analysts at Wedbush cut their Q1 2025 EPS estimates for Bicara Therapeutics in a note issued to investors ...

Stock analysts at Zacks Research issued their Q1 2025 earnings estimates for shares of Core Laboratories in a research report ...

Chardan Capital reissued their buy rating on shares of Clearside Biomedical (NASDAQ:CLSD – Free Report) in a research note published on Friday morning,Benzinga reports. Chardan Capital currently has a ...

Cantor Fitzgerald reiterated their overweight rating on shares of COMPASS Pathways (NASDAQ:CMPS – Free Report) in a report published on Friday morning,Benzinga reports. A number of other analysts also ...

Analysts at Zacks Research increased their Q3 2025 earnings per share estimates for Martin Marietta Materials in a research ...

Research analysts at Brookline Capital Management decreased their Q1 2025 earnings per share estimates for Perspective Therapeutics in a report issued on Wednesday, March 26th. Brookline Capital ...